Effect of Vernonia Cinerea Lozenges as a Smoking Cessation Aid in Patients With Non-communicable Diseases - Trial NCT06268002
Access comprehensive clinical trial information for NCT06268002 through Pure Global AI's free database. This phase not specified trial is sponsored by Chulalongkorn University and is currently Completed. The study focuses on Smoking Cessation. Target enrollment is 93 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chulalongkorn University
Timeline & Enrollment
N/A
Sep 01, 2017
Dec 31, 2021
Primary Outcome
continuous abstinence rate
Summary
Vernonia cinerea is an herbal which has been recorded in many Thai herbal formulation and
 Thai traditional medicine has used this herbal for treating various diseases included
 hypertension, asthma, fever, hepatitis, kidney stone and smoking cessation. Now aday there
 are more interest for using Vernonia cinerea as a medication to aid smoker to quit smoking
 because it is cheaper than other current therapeutic medications. The objective of this study
 is to evaluate efficacy and safety of Vernonia cinerea lozenge for smoking cessation when
 compared to placebo.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06268002
Non-Device Trial